Compare Amphastar Pharmaceuticals Inc (AMPH) vs Motorola Solutions Inc (MSI) Price & Performance

AMPH trades at $18.72, down 1.58% with bearish technical signals despite oversold RSI readings. The company reported mixed Q1 2026 results with EPS of $0.42 missing estimates of $0.70, continuing a trend of recent earnings disappointments. Valuation metrics appear reasonable with P/E of 11.29 and P/B of 1.07, while profitability remains solid with 47.34% gross margins. Recent news includes a Zacks Strong Sell rating and ongoing securities law investigation.

The stock faces near-term headwinds from earnings misses and negative analyst sentiment, though current valuations provide some downside protection. Upside potential exists if the company can execute its strategic pivot to proprietary drugs and biosimilars while managing BAQSIMI discount pressures. Key risks include ongoing legal scrutiny and competitive pressures in the generic drug market.

Motorola Solutions (MSI) trades at $422.88, up 1.36% with a bullish technical outlook. The stock shows strong fundamentals with Q1 2026 EPS beating estimates at $3.37 versus $3.24 expected, and a robust net income margin of 17.61%. Recent news highlights AI expansion in public safety, including the $1.5 billion acquisition of D-Fend Solutions, enhancing its competitive edge in counter-drone technology.

Outlook remains positive with a consensus price target of $512.33, indicating 21% upside. Risks include high valuation multiples like a P/E of 34.1 and increased debt from acquisitions. The company's focus on mission-critical AI and a $15.7 billion backlog supports growth, but investors should monitor integration execution and macroeconomic pressures on public spending.